Patients with mRCC survive longer at high-volume centersSeptember 4, 2018Renal Cell CarcinomaGenitourinary Cancer
Sunitinib for RCC: Side effects predictable, manageable, and reversibleAugust 31, 2018Renal Cell CarcinomaGenitourinary Cancer
Sunitinib alone not inferior to nephrectomy-sunitinib in metastatic RCCAugust 27, 2018Renal Cell CarcinomaGenitourinary Cancer
Study sheds new light on prognostic factors in PRCCAugust 24, 2018Renal Cell CarcinomaGenitourinary Cancer
Hypofractionated radiation has untapped potential as RCC mets therapyAugust 22, 2018Renal Cell CarcinomaGenitourinary Cancer
Increasing incidence of metastatic RCC raises concerns for SREsAugust 22, 2018Renal Cell CarcinomaGenitourinary Cancer
Leptin expression may help differentiate renal lesionsAugust 17, 2018Renal Cell CarcinomaGenitourinary Cancer
CT features associated with (some) ccRCC subtypesAugust 14, 2018Renal Cell CarcinomaGenitourinary Cancer
Rare clear cell papillary RCC has indolent courseAugust 6, 2018Renal Cell CarcinomaGenitourinary Cancer
Conditional OS estimates show upfront TKI benefit in mRCCAugust 3, 2018Renal Cell CarcinomaGenitourinary Cancer
Gene assays reveal some ‘unknown primary’ cancers as RCCJuly 25, 2018Renal Cell CarcinomaGenitourinary Cancer
Many actionable mutations may be missed in current testing of advanced RCCJuly 9, 2018Renal Cell CarcinomaGenitourinary Cancer
KEYNOTE-427: Pembrolizumab monotherapy shows promise in accRCCJune 25, 2018Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
